Passive Antibodies Against COVID-19 With EVUSHELD in Vaccine Non-responsive CLL

NCT05465876 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding pulled

Conditions

Chronic Lymphocytic Leukemia
COVID-19

Interventions

BIOLOGICAL: EVUSHELD

Sponsor

Sunnybrook Health Sciences Centre

Collaborators

[object Object]